Kahan, Z., Gil-Gil, M., Ruiz-Borrego, M., Carrasco, E., Ciruelos, E., Munoz, M., . . . Martin, M. (2021). Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
Citación estilo ChicagoKahan, Zsuzsanna, et al. Health-related Quality of Life With Palbociclib Plus Endocrine Therapy Versus Capecitabine in Postmenopausal Patients With Hormone Receptor-positive Metastatic Breast Cancer: Patient-reported Outcomes in the PEARL Study. 2021.
Cita MLAKahan, Zsuzsanna, et al. Health-related Quality of Life With Palbociclib Plus Endocrine Therapy Versus Capecitabine in Postmenopausal Patients With Hormone Receptor-positive Metastatic Breast Cancer: Patient-reported Outcomes in the PEARL Study. 2021.